BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 16247348)

  • 1. Renal tumor radiofrequency ablation.
    Slabaugh TK; Ogan K
    Minerva Urol Nefrol; 2005 Dec; 57(4):261-9. PubMed ID: 16247348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of a novel bipolar radiofrequency ablation system for renal masses.
    Okhunov Z; Roy O; Duty B; Waingankar N; Herati A; Morgenstern N; Sheikh-Fayyaz S; Kavoussi LR
    BJU Int; 2012 Sep; 110(5):688-91. PubMed ID: 22394594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimally invasive nephron-sparing surgery.
    Berger A; Crouzet S; Canes D; Haber GP; Gill IS
    Curr Opin Urol; 2008 Sep; 18(5):462-6. PubMed ID: 18670268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of renal tumors with radiofrequency ablation.
    Wagner AA; Solomon SB; Su LM
    J Endourol; 2005; 19(6):643-52; discussion 652-3. PubMed ID: 16053352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central and deep renal tumors can be effectively ablated: radiofrequency ablation outcomes with fiberoptic peripheral temperature monitoring.
    Wingo MS; Leveillee RJ
    J Endourol; 2008 Jun; 22(6):1261-7. PubMed ID: 18484892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up.
    Forauer AR; Dewey BJ; Seigne JD
    Urol Oncol; 2014 Aug; 32(6):869-76. PubMed ID: 24946958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A critical analysis of the actual role of minimally invasive surgery and active surveillance for kidney cancer.
    Heuer R; Gill IS; Guazzoni G; Kirkali Z; Marberger M; Richie JP; de la Rosette JJ
    Eur Urol; 2010 Feb; 57(2):223-32. PubMed ID: 19853989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimally invasive ablative technique for the treatment of small renal masses.
    Gulur D; Crow P; Keeley FX
    Arch Ital Urol Androl; 2009 Jun; 81(2):100-6. PubMed ID: 19760865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Perioperative outcomes and mid-term results of radiofrequency ablation and partial nephrectomy in indications of renal tumor treatment and imperative nephron-sparing procedure].
    Arnoux V; Descotes JL; Sengel C; Terrier N; Rambeaud JJ; Long JA
    Prog Urol; 2013 Feb; 23(2):99-104. PubMed ID: 23352302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney radiofrequency ablation for small renal tumors: oncologic efficacy.
    Joniau S; Tailly T; Goeman L; Blyweert W; Gontero P; Joyce A
    J Endourol; 2010 May; 24(5):721-8. PubMed ID: 20477540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiofrequency ablation for the treatment of small renal masses: safety and oncologic efficacy.
    Joniau S; Tsivian M; Gontero P
    Minerva Urol Nefrol; 2011 Sep; 63(3):227-36. PubMed ID: 21993321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Ablation and Minimally Invasive Techniques in the Management of Small Renal Masses.
    Salagierski M; Wojciechowska A; Zając K; Klatte T; Thompson RH; Cadeddu JA; Kaouk J; Autorino R; Ahrar K; Capitanio U;
    Eur Urol Oncol; 2018 Oct; 1(5):395-402. PubMed ID: 31158078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Percutaneous thermal ablation of renal neoplasms].
    Tacke J; Mahnken AH; Günther RW
    Rofo; 2005 Dec; 177(12):1631-40. PubMed ID: 16333785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiofrequency ablation versus partial nephrectomy for the treatment of clinical stage 1 renal masses: a systematic review and meta-analysis.
    Wang S; Qin C; Peng Z; Cao Q; Li P; Shao P; Ju X; Meng X; Lu Q; Li J; Wang M; Zhang Z; Gu M; Zhang W; Yin C
    Chin Med J (Engl); 2014; 127(13):2497-503. PubMed ID: 24985591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Focal therapy for small renal masses : Observation, ablation or surgery].
    Wendler JJ; Friebe B; Baumunk D; Blana A; Franiel T; Ganzer R; Hadaschik B; Henkel T; Köhrmann KU; Köllermann J; Kuru T; Machtens S; Roosen A; Salomon G; Schlemmer HP; Sentker L; Witzsch U; Liehr UB; Ricke J; Schostak M
    Urologe A; 2016 May; 55(5):594-606. PubMed ID: 27119957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiofrequency ablation of small renal tumors.
    Johnson DB; Cadeddu JA
    Expert Rev Anticancer Ther; 2004 Feb; 4(1):77-83. PubMed ID: 14748659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of renal masses with laparoscopic-guided radiofrequency ablation versus laparoscopic partial nephrectomy.
    Bird VG; Carey RI; Ayyathurai R; Bird VY
    J Endourol; 2009 Jan; 23(1):81-8. PubMed ID: 19118475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
    Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
    Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal functional outcomes for tumours in a solitary kidney managed by ablative or extirpative techniques.
    Raman JD; Raj GV; Lucas SM; Williams SK; Lauer EM; Ahrar K; Matin SF; Leveillee RJ; Cadeddu JA
    BJU Int; 2010 Feb; 105(4):496-500. PubMed ID: 19681900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.